Department of Medicine, Division of Nephrology, Stanford University School of Medicine, Palo Alto, CA, USA.
Department of Surgery, Stanford University School of Medicine, Palo Alto, CA, USA.
J Vasc Access. 2021 Jul;22(4):509-514. doi: 10.1177/1129729820913692. Epub 2020 Apr 18.
There is renewed demand to accelerate innovation in nephrology; public and private sectors are creating programs to support its growth. The Stanford Biodesign innovation process, first developed in 2000, provides a roadmap for health technology and device innovation. There is insufficient published guidance on the application of the Biodesign process in the generation of novel devices to address nephrology- and/or dialysis-related clinical unmet needs. We present "needs finding," the initial part of the identify phase in the Biodesign innovation process and how it may be utilized for nephrology- and/or dialysis-related innovation. We describe here how to apply the Biodesign process to identify unmet dialysis-related needs, with the use of specific case-based examples based on observations within a hemodialysis unit. We then explore how to develop these needs using background research, direct clinical observations, interviews, documentation of observations and interview findings, and development of multiple needs statements. We conclude that there is an opportunity for nephrology innovators to use this methodology broadly in order to identify areas for innovation and initiated the development on novel solutions to be introduced into patient care.
人们对加速肾脏病学创新的需求再次高涨;公共和私营部门正在创建各种项目来支持其发展。斯坦福 Biodesign 创新流程最初于 2000 年开发,为医疗技术和设备创新提供了路线图。关于将 Biodesign 流程应用于生成新颖设备以满足肾脏病学和/或透析相关临床未满足需求方面,发表的指导意见不足。我们提出了“需求发现”,即 Biodesign 创新流程中识别阶段的初始部分,以及它如何可用于肾脏病学和/或透析相关创新。我们在这里描述如何应用 Biodesign 流程来识别未满足的透析相关需求,并使用基于血液透析单元内观察的具体案例示例。然后,我们探讨了如何使用背景研究、直接临床观察、访谈、观察和访谈结果的记录以及多个需求陈述的制定来开发这些需求。我们得出结论,肾脏病学创新者有机会广泛使用这种方法来确定创新领域,并着手开发将引入患者护理的新颖解决方案。